- Home
- ACLX vs TBBK Comparison
ACLX vs TBBK Comparison
Compare ACLX & TBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACLX | TBBK |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 2.3B |
| IPO Year | 2022 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ACLX | TBBK |
|---|---|---|
| Price | $114.53 | $53.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $115.85 | $69.00 |
| AVG Volume (30 Days) | ★ 3.4M | 440.5K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.69 |
| EPS | N/A | ★ 4.92 |
| Revenue | $22,286,000.00 | ★ $141,147,000.00 |
| Revenue This Year | $329.40 | N/A |
| Revenue Next Year | $151.37 | $11.90 |
| P/E Ratio | ★ N/A | $10.73 |
| Revenue Growth | N/A | ★ 20.85 |
| 52 Week Low | $47.86 | $40.51 |
| 52 Week High | $114.80 | $81.65 |
Technical Indicators
Market Signals| Indicator | ACLX | TBBK |
|---|---|---|
| Relative Strength Index (RSI) | 83.40 | 41.09 |
| Support Level | $66.06 | $49.50 |
| Resistance Level | $114.80 | $53.83 |
| Average True Range (ATR) | 0.34 | 2.27 |
| MACD | -0.89 | 0.28 |
| Stochastic Oscillator | 75.89 | 40.12 |
Price Performance
Historical ComparisonAbout ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.